Avatrombopag
≥97%
- Product Code: 99609
CAS:
570406-98-3
| Molecular Weight: | 649.65 g./mol | Molecular Formula: | C₂₉H₃₄Cl₂N₆O₃S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Avatrombopag is primarily used to treat thrombocytopenia, a condition characterized by low platelet counts, in patients with chronic liver disease who are scheduled to undergo a medical or dental procedure. It works by stimulating the production of platelets, thereby reducing the risk of bleeding during and after the procedure. This medication is particularly beneficial for patients who cannot receive platelet transfusions or for whom transfusions are ineffective. It is administered orally, making it convenient for patients, and its dosage is typically adjusted based on the patient’s platelet count. By increasing platelet levels, avatrombopag helps ensure safer surgical outcomes and minimizes complications associated with low platelet counts.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Gray Solid |
| PURITY | 96.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | £111.28 |
+
-
|
| 0.050 | 10-20 days | £348.75 |
+
-
|
| 0.250 | 10-20 days | £1,047.62 |
+
-
|
| 1.000 | 10-20 days | £2,257.18 |
+
-
|
Avatrombopag
Avatrombopag is primarily used to treat thrombocytopenia, a condition characterized by low platelet counts, in patients with chronic liver disease who are scheduled to undergo a medical or dental procedure. It works by stimulating the production of platelets, thereby reducing the risk of bleeding during and after the procedure. This medication is particularly beneficial for patients who cannot receive platelet transfusions or for whom transfusions are ineffective. It is administered orally, making it convenient for patients, and its dosage is typically adjusted based on the patient’s platelet count. By increasing platelet levels, avatrombopag helps ensure safer surgical outcomes and minimizes complications associated with low platelet counts.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :